期刊
AMERICAN JOURNAL OF HEMATOLOGY
卷 91, 期 1, 页码 113-122出版社
WILEY
DOI: 10.1002/ajh.24203
关键词
-
类别
资金
- Leukemia & Lymphoma Society [6270-13]
- NIH-NCI [K08CA172215]
T-cell lymphoma pathogenesis and classification have, until recently, remained enigmatic. Recently performed whole-exome sequencing and gene-expression profiling studies have significant implications for their classification and treatment. Recurrent genetic modifications in antigen (signal 1), costimulatory (signal 2), or cytokine receptors (signal 3), and the tyrosine kinases and other signaling proteins they activate, have emerged as important therapeutic targets in these lymphomas. Many of these genetic modifications do not function in a cell-autonomous manner, but require the provision of ligand(s) by constituents of the tumor microenvironment, further supporting the long-appreciated view that these lymphomas are dependent upon and driven by their microenvironment. Therefore, the seemingly disparate fields of genomics and immunology are converging. A unifying 3 signal model for T-cell lymphoma pathogenesis that integrates these findings will be presented, and its therapeutic implications briefly reviewed. (c) 2015 Wiley Periodicals, Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据